Cargando…
Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease
The ongoing coronavirus pandemic has been a burden on the worldwide population, with mass fatalities and devastating socioeconomic consequences. It has particularly drawn attention to the lack of approved small-molecule drugs to inhibit SARS coronaviruses. Importantly, lessons learned from the SARS...
Autores principales: | Hajbabaie, Roxanna, Harper, Matthew T., Rahman, Taufiq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924369/ https://www.ncbi.nlm.nih.gov/pubmed/33672721 http://dx.doi.org/10.3390/molecules26041134 |
Ejemplares similares
-
Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach
por: Augustin, Teresa L., et al.
Publicado: (2020) -
Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
por: Chou, Chi-Yuan, et al.
Publicado: (2008) -
Structural and functional characterization of MERS coronavirus papain-like protease
por: Lin, Min-Han, et al.
Publicado: (2014) -
Targeting papain-like protease for broad-spectrum coronavirus inhibition
por: Yuan, Shuofeng, et al.
Publicado: (2022) -
In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease
por: Huynh, Tien, et al.
Publicado: (2021)